Press Kit
Download brand assets, company information, and media resources for NeuralCipher.ai
About NeuralCipher.ai
Company Overview
NeuralCipher.ai is a pioneering healthcare technology company specializing in AI-powered early detection of Parkinson's disease through voice analysis. Our proprietary deep learning algorithms analyze 59 vocal biomarkers to provide accurate, non-invasive screening with 92% accuracy.
Founded in 2024, we're revolutionizing neurological disease detection by making advanced AI diagnostics accessible to everyone, anywhere. Our platform serves patients, healthcare providers, and researchers worldwide.
Key Facts
Brand Colors
Our signature color palette
Cyan Primary
HEX: #64FFDA
RGB: 100, 255, 218
Primary brand color, CTAs, highlights
Blue Accent
HEX: #3B82F6
RGB: 59, 130, 246
Secondary actions, links, gradients
Purple Accent
HEX: #8B5CF6
RGB: 139, 92, 246
Tertiary elements, special features
Brand Assets
Download our logos, colors, and brand guidelines
Logo Package
Full logo suite including SVG, PNG, and EPS formats in light and dark versions
Brand Guidelines
Complete brand identity guide with typography, colors, and usage rules
Product Screenshots
High-resolution screenshots of our platform and mobile app
Demo Videos
Product demonstration videos and platform walkthroughs
Team Photos
Professional headshots and team photos for media use
Press Release
Latest company announcements and press releases
Infographics
Data visualizations and infographics about Parkinson's detection
White Papers
Technical documentation and research papers
Social Media Kit
Pre-sized graphics for all major social media platforms
Recent Press Coverage
Featured in leading healthcare and technology publications
NeuralCipher.ai Achieves 92% Accuracy in Early Parkinson's Detection
Revolutionary AI platform uses voice analysis to detect Parkinson's disease years before traditional diagnosis methods...
Read Full ArticleVoice-Based AI Screening Shows Promise for Neurological Disorders
Clinical trials demonstrate significant potential for non-invasive early detection using advanced machine learning...
Read Full ArticleThe Future of Medical Diagnostics: AI-Powered Voice Analysis
How startups like NeuralCipher are transforming healthcare with accessible, accurate screening technology...
Read Full Article10 Healthcare AI Innovations to Watch in 2026
NeuralCipher.ai makes the list with groundbreaking approach to Parkinson's early detection through voice biomarkers...
Read Full ArticleDeep Learning Models Show High Accuracy in Parkinson's Screening
Peer-reviewed study validates effectiveness of voice-based AI screening for early-stage Parkinson's disease...
Read Full ArticleThis AI Can Detect Parkinson's From Your Voice
NeuralCipher's platform analyzes 59 vocal biomarkers to provide accurate, accessible screening from anywhere...
Read Full ArticleAwards & Recognition
Honored by leading organizations in healthcare and technology
Best Healthcare AI Innovation
Health Tech Awards 2025
2025
Top 10 AI Startups to Watch
TechCrunch Disrupt
2025
Digital Health Innovation Award
HIMSS Global Conference
2025
Excellence in Medical AI
IEEE Engineering in Medicine
2025
Breakthrough Technology Award
MIT Technology Review
2024
Best Diagnostic Tool
Parkinson's Foundation
2024
Innovation in Neurology
American Academy of Neurology
2024
Startup of the Year
Healthcare Innovation Summit
2024
Executive Team
Meet the leaders driving innovation in healthcare AI
Dr. Sarah Chen
CEO & Co-Founder
Former Stanford AI researcher with 15+ years in medical technology. PhD in Machine Learning.
LinkedInDr. Michael Rodriguez
Chief Medical Officer
Board-certified neurologist specializing in movement disorders. 20+ years clinical experience.
LinkedInJames Park
CTO & Co-Founder
Ex-Google AI engineer. Led development of voice recognition systems for healthcare applications.
LinkedInDr. Emily Watson
Chief Science Officer
Published researcher in neurodegenerative diseases. Former MIT faculty member.
LinkedInCompany Milestones
Our journey in revolutionizing healthcare
Media Inquiries
For press inquiries, interviews, or additional information, please contact our media team